A detailed history of Ashton Thomas Securities, LLC transactions in Vericel Corp stock. As of the latest transaction made, Ashton Thomas Securities, LLC holds 55 shares of VCEL stock, worth $2,419. This represents 0.0% of its overall portfolio holdings.

Number of Shares
55
Holding current value
$2,419
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$42.25 - $53.56 $2,323 - $2,945
55 New
55 $2.32 Million

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.08B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Ashton Thomas Securities, LLC Portfolio

Follow Ashton Thomas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ashton Thomas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ashton Thomas Securities, LLC with notifications on news.